These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
528 related items for PubMed ID: 16021566
1. Synchronous endometrioid carcinomas of the uterine corpus and ovary: alterations in the beta-catenin (CTNNB1) pathway are associated with independent primary tumors and favorable prognosis. Irving JA, Catasús L, Gallardo A, Bussaglia E, Romero M, Matias-Guiu X, Prat J. Hum Pathol; 2005 Jun; 36(6):605-19. PubMed ID: 16021566 [Abstract] [Full Text] [Related]
2. Molecular genetic alterations in endometrioid carcinomas of the ovary: similar frequency of beta-catenin abnormalities but lower rate of microsatellite instability and PTEN alterations than in uterine endometrioid carcinomas. Catasús L, Bussaglia E, Rodrguez I, Gallardo A, Pons C, Irving JA, Prat J. Hum Pathol; 2004 Nov; 35(11):1360-8. PubMed ID: 15668893 [Abstract] [Full Text] [Related]
3. Diverse mechanisms of beta-catenin deregulation in ovarian endometrioid adenocarcinomas. Wu R, Zhai Y, Fearon ER, Cho KR. Cancer Res; 2001 Nov 15; 61(22):8247-55. PubMed ID: 11719457 [Abstract] [Full Text] [Related]
4. Pathogenetic pathways in ovarian endometrioid adenocarcinoma: a molecular study of 29 cases. Geyer JT, López-García MA, Sánchez-Estevez C, Sarrió D, Moreno-Bueno G, Franceschetti I, Palacios J, Oliva E. Am J Surg Pathol; 2009 Aug 15; 33(8):1157-63. PubMed ID: 19542870 [Abstract] [Full Text] [Related]
7. Ovarian carcinomas, including secondary tumors: diagnostically challenging areas. Prat J. Mod Pathol; 2005 Feb 15; 18 Suppl 2():S99-111. PubMed ID: 15492758 [Abstract] [Full Text] [Related]
8. Mutations in the beta-catenin gene (CTNNB1) in endometrioid ovarian carcinomas. Palacios J, Gamallo C. Cancer Res; 1998 Apr 01; 58(7):1344-7. PubMed ID: 9537226 [Abstract] [Full Text] [Related]
9. Synchronous endometrial and ovarian carcinomas: analysis of genetic relationship of the tumors. Nishimura N, Hachisuga T, Nabeshima K, Kawarabayashi T. Int J Oncol; 2005 Dec 01; 27(6):1519-26. PubMed ID: 16273207 [Abstract] [Full Text] [Related]
10. Genetics of synchronous uterine and ovarian endometrioid carcinoma: combined analyses of loss of heterozygosity, PTEN mutation, and microsatellite instability. Fujii H, Matsumoto T, Yoshida M, Furugen Y, Takagaki T, Iwabuchi K, Nakata Y, Takagi Y, Moriya T, Ohtsuji N, Ohtsuji M, Hirose S, Shirai T. Hum Pathol; 2002 Apr 01; 33(4):421-8. PubMed ID: 12055677 [Abstract] [Full Text] [Related]
11. Microsatellite instability and mismatch repair protein defects in ovarian epithelial neoplasms in patients 50 years of age and younger. Jensen KC, Mariappan MR, Putcha GV, Husain A, Chun N, Ford JM, Schrijver I, Longacre TA. Am J Surg Pathol; 2008 Jul 01; 32(7):1029-37. PubMed ID: 18469706 [Abstract] [Full Text] [Related]
13. Expression of cadherins and catenins correlates with distinct histologic types of ovarian carcinomas. Sarrió D, Moreno-Bueno G, Sánchez-Estévez C, Bañón-Rodríguez I, Hernández-Cortés G, Hardisson D, Palacios J. Hum Pathol; 2006 Aug 01; 37(8):1042-9. PubMed ID: 16867867 [Abstract] [Full Text] [Related]
14. Abnormalities of the APC/beta-catenin pathway in endometrial cancer. Moreno-Bueno G, Hardisson D, Sánchez C, Sarrió D, Cassia R, García-Rostán G, Prat J, Guo M, Herman JG, Matías-Guiu X, Esteller M, Palacios J. Oncogene; 2002 Nov 14; 21(52):7981-90. PubMed ID: 12439748 [Abstract] [Full Text] [Related]
15. Frameshift mutations in the bax gene are not involved in development of ovarian endometrioid carcinoma. Cao SN, Chang KH, Luthra R, Liu J. Mod Pathol; 2003 Oct 14; 16(10):1048-52. PubMed ID: 14559989 [Abstract] [Full Text] [Related]
16. Loss of heterozygosity and mutational analysis of the PTEN/MMAC1 gene in synchronous endometrial and ovarian carcinomas. Lin WM, Forgacs E, Warshal DP, Yeh IT, Martin JS, Ashfaq R, Muller CY. Clin Cancer Res; 1998 Nov 14; 4(11):2577-83. PubMed ID: 9829719 [Abstract] [Full Text] [Related]
17. Development and applications of a beta-catenin oligonucleotide microarray: beta-catenin mutations are dominantly found in the proximal colon cancers with microsatellite instability. Kim IJ, Kang HC, Park JH, Shin Y, Ku JL, Lim SB, Park SY, Jung SY, Kim HK, Park JG. Clin Cancer Res; 2003 Aug 01; 9(8):2920-5. PubMed ID: 12912937 [Abstract] [Full Text] [Related]
18. p16 expression in primary ovarian mucinous and endometrioid tumors and metastatic adenocarcinomas in the ovary: utility for identification of metastatic HPV-related endocervical adenocarcinomas. Vang R, Gown AM, Farinola M, Barry TS, Wheeler DT, Yemelyanova A, Seidman JD, Judson K, Ronnett BM. Am J Surg Pathol; 2007 May 01; 31(5):653-63. PubMed ID: 17460447 [Abstract] [Full Text] [Related]
19. Histologic type, organ of origin, and Wnt pathway status: effect on gene expression in ovarian and uterine carcinomas. Shedden KA, Kshirsagar MP, Schwartz DR, Wu R, Yu H, Misek DE, Hanash S, Katabuchi H, Ellenson LH, Fearon ER, Cho KR. Clin Cancer Res; 2005 Mar 15; 11(6):2123-31. PubMed ID: 15788657 [Abstract] [Full Text] [Related]
20. [Mutation analysis of the beta-catenin gene in epithelial carcinomas of the ovaries]. Tanyi J, Páy A, Rigó J, Nagy B, Papp Z. Orv Hetil; 2000 May 21; 141(21):1115-9. PubMed ID: 10876313 [Abstract] [Full Text] [Related] Page: [Next] [New Search]